Evidence map›Paper›PMID 21233256›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2011

Predictors of early versus late smoking abstinence within a 24-month disease management program.

Lisa Sanderson Cox, Jo A Wick, Niaman Nazir, A Paula Cupertino, Laura M Mussulman, Jasjit S Ahluwalia, Edward F Ellerbeck

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00440115 (Disease Management for Smokers in Rural Primary Care), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00440115 phase3completednot on this map

Disease Management for Smokers in Rural Primary Care

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2009 to 2010Enrolled750ConditionsSmoking CessationArmsHigh intensity disease management, Low intensity disease management, Comparison group, Bupropion
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Dependence and withdrawal-induced craving predict abstinence in an incentive-based model of smoking relapse.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Trial
  7. Trial
  8. Article
  9. Indicators related to smoking cessation in Brazil, National Health Survey, 2013 and 2019 editions.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2022
    Article
  10. Article
  11. Motivational interviewing for smoking cessation.The Cochrane database of systematic reviews · 2019
    Review
  12. Ongoing self-engagement in quit attempts and cessation outcomes among rural smokers who were unable to quit after 2 years of repeated interventions.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lisa Sanderson CoxDepartment of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS 66160, USA.
Jo A Wick
Niaman Nazir
A Paula Cupertino
Laura M Mussulman
Jasjit S Ahluwalia
Edward F Ellerbeck

Funding

Disease Management for Smokers in Rural Primary CareR01CA101963 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ELLERBECK, EDWARD F. · 2003 to 2013
$6.3M
The Center for Health Disparities Research, Engagement, and Training (CeHDRET)P60MD003422 · NIMHD · UNIVERSITY OF MINNESOTA · PI EVERSON-ROSE, SUSAN A. · 2009 to 2013
$6.1M
NCI NIH HHS CA 1102390NCI NIH HHS R01 CA101963NIMHD NIH HHS 1P60MD003422
6 · The paper itself

Abstract

introductionStandard smoking cessation treatment studies have been limited to 6- to 12-month follow-up, and examination of predictors of abstinence has been restricted to this timeframe. The KanQuit study enrolled 750 rural smokers across all stages of readiness to stop smoking and provided pharmacotherapy management and/or disease management, including motivational interviewing (MI) counseling every 6 months over 2 years. This paper examines differences in predictors of abstinence following initial (6-month) and extended (24-month) intervention.

methodsBaseline variables were analyzed as potential predictors of self-reported smoking abstinence at Month 6 and at Month 24. Chi-square tests, 2-sample t tests, and multiple logistic regression analyses were used to identify predictors of abstinence among 592 participants who completed assessment at baseline and Months 6 and 24.

resultsControlling for treatment group, the final regression models showed that male gender and lower baseline cigarettes per day predicted abstinence at both 6 and 24 months. While remaining significant, the relative advantage of being male decreased over time. Global motivation to stop smoking, controlled motivation, and self-efficacy predicted abstinence at 6 months but did not predict abstinence at Month 24. In contrast, stage of change was strongly predictive of 24-month smoking status.

conclusionsWhile the importance of some predictors of successful smoking cessation appeared to diminish over time, initial lack of interest in cessation and number of cigarettes per day strongly predicted continued smoking following a 2-year program.

Indexed as

AdultDisease ManagementFemaleHumansLogistic ModelsMaleMiddle AgedSmoking Cessation

Identifiers

PMID21233256
PMCPMC3045464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.